These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 28970836)

  • 41. Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease
    Zhu W; Zhou Y; Tsao R; Dong H; Zhang H
    Front Nutr; 2022; 9():861854. PubMed ID: 35662935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota.
    Han R; Ma J; Li H
    Front Med; 2018 Dec; 12(6):645-657. PubMed ID: 30178233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
    Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
    J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment.
    Yang M; Zhang CY
    World J Gastroenterol; 2021 Feb; 27(8):677-691. PubMed ID: 33716447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dietary fructose as a metabolic risk factor.
    Sindhunata DP; Meijnikman AS; Gerdes VEA; Nieuwdorp M
    Am J Physiol Cell Physiol; 2022 Sep; 323(3):C847-C856. PubMed ID: 35876289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice.
    Yang Y; Jiang X; Pandol SJ; Han YP; Zheng X
    Front Physiol; 2021; 12():739174. PubMed ID: 34764881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis.
    Plaza-Díaz J; Solis-Urra P; Aragón-Vela J; Rodríguez-Rodríguez F; Olivares-Arancibia J; Álvarez-Mercado AI
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33546191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut microbiota and non-alcoholic fatty liver disease.
    Gkolfakis P; Dimitriadis G; Triantafyllou K
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):572-81. PubMed ID: 26663004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Excess dietary fructose does not alter gut microbiota or permeability in humans: A pilot randomized controlled study.
    Alemán JO; Henderson WA; Walker JM; Ronning A; Jones DR; Walter PJ; Daniel SG; Bittinger K; Vaughan R; MacArthur R; Chen K; Breslow JL; Holt PR
    J Clin Transl Sci; 2021; 5(1):e143. PubMed ID: 34422323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice.
    Cavallari JF; Pokrajac NT; Zlitni S; Foley KP; Henriksbo BD; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E305-E314. PubMed ID: 32516028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
    Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F
    Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice.
    Xie F; Xu HF; Zhang J; Liu XN; Kou BX; Cai MY; Wu J; Dong JL; Meng QH; Wang Y; Chen D; Zhang Y
    Front Immunol; 2022; 13():974872. PubMed ID: 36466835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.
    Ritze Y; Bárdos G; Claus A; Ehrmann V; Bergheim I; Schwiertz A; Bischoff SC
    PLoS One; 2014; 9(1):e80169. PubMed ID: 24475018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease.
    Yu S; Li C; Ji G; Zhang L
    Front Pharmacol; 2021; 12():783393. PubMed ID: 34867414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
    Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
    BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).
    Alwahsh SM; Gebhardt R
    Arch Toxicol; 2017 Apr; 91(4):1545-1563. PubMed ID: 27995280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.
    Arab JP; Arrese M; Shah VH
    Hepatol Res; 2020 Apr; 50(4):407-418. PubMed ID: 31840358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.